Journal of Chemotherapy Issues Research Articles in Vol. 34, No. 2
March 24, 2022
March 24, 2022
ABINGDON, England, March 24 -- The Journal of Chemotherapy, a peer reviewed journal that says it focuses on antimicrobial and antitumor chemotherapy from the American Society for Microbiology, published research articles on the following topics in its Vol. 34, No. 2 edition:
Reviews:
* The use of antiviral drugs in children
* Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor-naive/untreated ALK-positive advanced non-small-cell lung cancer . . .
Reviews:
* The use of antiviral drugs in children
* Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor-naive/untreated ALK-positive advanced non-small-cell lung cancer . . .